logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
Mixed lineage kinase 7 Inhibitors (IC50, Ki)
Structure
Compound Name
Standard Type
Standard Values (in nM)
VemurafenibIC5023.0 [1], 31.4 [2]
4-(3-Pyridin-2-YL-1H-pyrazol-4-YL)quinolineIC501400.0 [1]
LY-2090314IC5020000.0 [1]
LY-3009120IC5039.0 [1]
3-Imidazo[1,2-a]pyridin-3-yl-4-[10-(morpholine-4-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]pyrrole-2,5-dioneIC5013400.0 [1]

References
This online resource may be cited as follows
MLA
"Quest DatabaseMixed lineage kinase 7 Inhibitors (IC50, Ki)." AAT Bioquest, Inc.20 Jan2026https://www.aatbio.com/data-sets/mixed-lineage-kinase-7-inhibitors-ic50-ki.
APA
AAT Bioquest, Inc. (2026January 20). Quest DatabaseMixed lineage kinase 7 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/mixed-lineage-kinase-7-inhibitors-ic50-ki.
BibTeXEndNoteRefMan